hair loss help.com is your complete hair loss guide and resource for info about Propecia, Rogaine, minoxidil, transplants, thymuskin, Revivogen, folliguard, tricomin and other hair loss and baldness remedies
Published daily by Hairlosshelp.com, your #1 source of hair loss information

MiN New York Unveils Their Answer to Hair Loss and Thinning Hair

Posted on February 18th, 2007 in Hair Product News by admin | 2,166 Views | Print This Post/Page

New York, NY – MiN, a NY-based cosmetic company specializing in hair growth products, recently unveiled their latest hair loss treatment.  Dubbed “AGENT”, MiN claims it’s a “breakthrough hair regeneration formula developed to give men the most effective results”.

Min says that it’s the only formula available that contains three globally patented hair regeneration ingredients.

The AGENT topical solution contains 5% Minoxidil, 2% Kopexil (DHT inhibitor), 2% Procapil (DHT inhibitor), and 2% copper peptide Y3.  AGENT utilizes a time-release nanosome-encapsulated technology to deliver their active ingredients closer to the root of the problem.

Although Min makes a DHT Defense Cleansing System which is safe to use by both men and women, AGENT is restricted to use by men because it contains 5% Minoxidil which has not been FDA approved for use by women.

The AGENT product retails for $36 (US) for a 60ml/2FlOz bottle.

For more information on MiN New York and their products visit the company’s website at http://www.MiN.com.

 
Share this article:These icons link to social bookmarking sites where readers can share and discover new web pages.
  • blinkbits
  • BlinkList
  • blogmarks
  • co.mments
  • connotea
  • del.icio.us
  • De.lirio.us
  • digg
  • Fark
  • feedmelinks
  • Furl
  • LinkaGoGo
  • Ma.gnolia
  • NewsVine
  • Netvouz
  • RawSugar
  • Reddit
  • scuttle
  • Shadows
  • Simpy
  • YahooMyWeb

Rate this article (click on stars)
1 Star2 Stars3 Stars4 Stars5 Stars (4 votes, average: 2.75 out of 5)
Loading ... Loading ...



Post a comment

You must be logged in to post a comment.